BNC-210
- Generic Name
- BNC-210
A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)
- First Posted Date
- 2021-07-06
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- Bionomics Limited
- Target Recruit Count
- 212
- Registration Number
- NCT04951076
- Locations
- 🇺🇸
ATTTUNE Study Clinical Trial Site, Jacksonville, Florida, United States
🇬🇧ATTUNE Study Clinical Trial Site, Stockton-on-Tees, United Kingdom
A Study of BNC210 in Elderly Patients With Agitation
- First Posted Date
- 2018-06-07
- Last Posted Date
- 2020-07-09
- Lead Sponsor
- Bionomics Limited
- Target Recruit Count
- 38
- Registration Number
- NCT03548194
- Locations
- 🇦🇺
Royal Melbourne Hospital, Melbourne, Victoria, Australia
🇦🇺Northern Health, Melbourne, Victoria, Australia
🇦🇺Western Health, Melbourne, Victoria, Australia
Phase II Study of BNC210 in PTSD
- First Posted Date
- 2016-10-14
- Last Posted Date
- 2023-02-27
- Lead Sponsor
- Bionomics Limited
- Target Recruit Count
- 193
- Registration Number
- NCT02933606
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath